Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and Nephrolithiasis

NCT03346369 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Secondary Hyperoxaluria
Nephrolithiasis

Interventions

DRUG: Lanthanum Carbonate

Sponsor

Universitair Ziekenhuis Brussel